Asian Paints Reports 4.5 Percent Decline in Annual Revenue Amid Weak Demand
Asian Paints, a global leader in the coatings industry, announced its financial results for the fiscal year ending March 31, 2025. The company reported a consolidated annual revenue of ₹3379.7 crore (₹284.5 billion), reflecting a 4.5% decline year-on-year, while standalone revenue dropped 5.4% to ₹2942.1 crore (₹247.6 billion).
In Q4 FY2024, consolidated revenue decreased 4.3% to ₹832.96 crore (₹70 billion) due to weak demand, shifting consumer preferences toward lower-priced products, and intensified competition. Despite a 1.8% volume growth in decorative paints in India, revenue fell 5.2%. However, the industrial segment grew 6.1%, driven by strong performance in general industrial and automotive coatings.
The company’s standalone PBDIT margin dropped 210 basis points to 18.5%, while the consolidated margin declined 220 basis points to 17.2%.
CEO Amit Syngle highlighted persistent demand challenges and unfavorable product mix affecting profitability. While international revenue dipped 1.5%, it grew 6% at constant exchange rates, with strong performance in the Middle East and Asia, offset by macroeconomic hurdles in Africa. Syngle remains cautiously optimistic about recovery, leveraging brand strength and operational efficiency.
Founded in 1942, Asian Paints is India’s largest paint company and the world’s top 10 coatings manufacturer, with 27 factories across 15 countries.
2026-08-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
EU Chemicals Regulatory Update: Practical Compliance Actions Following ECHA January 2026 Developments
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving
-
FDA Tightens the Solvent Side of Natural Color Production
-
India’s Tariff Cuts Could Lower Agrochemical Costs
-
FSANZ Moves Toward Approval of Insect-Resistant Corn COR121
-
Thymol Gel Wins EPA Approval for Beekeepers
-
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
Recommend Reading
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
Demand Fluctuations Drive Butadiene Market to Soar in August
-
Demand Side Enters at Lower Levels; ABS Rallies from Low Levels by End of December
-
Narrow Fluctuations in Phosphate Prices in China (9.5-9.11)
-
Cost-side support weakens, PTA price center of gravity continues to shift downward
-
Phosphate Market in August Stabilizes After Narrow Fluctuations in China